{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T03:01:32Z","timestamp":1779159692304,"version":"3.51.4"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T00:00:00Z","timestamp":1565654400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Methods"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.ymeth.2019.08.003","type":"journal-article","created":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T19:50:50Z","timestamp":1565812250000},"page":"24-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Peptidic transition state analogues as PRMT inhibitors"],"prefix":"10.1016","volume":"175","author":[{"given":"Yurui","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthijs J.","family":"van Haren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathaniel I.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ymeth.2019.08.003_b0005","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1242\/jcs.039933","article-title":"Human protein arginine methyltransferases in vivo \u2013 distinct properties of eight canonical members of the PRMT family","volume":"122","author":"Bedford","year":"2009","journal-title":"J. Cell Sci."},{"issue":"1","key":"10.1016\/j.ymeth.2019.08.003_b0010","doi-asserted-by":"crossref","first-page":"32","DOI":"10.4161\/cc.27353","article-title":"Protein arginine methylation of non-histone proteins and its role in diseases","volume":"13","author":"Wei","year":"2014","journal-title":"Cell Cycle"},{"issue":"16","key":"10.1016\/j.ymeth.2019.08.003_b0015","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1021\/bi102022e","article-title":"Mechanistic studies on transcriptional coactivator protein arginine methyltransferase 1","volume":"50","author":"Rust","year":"2011","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.ymeth.2019.08.003_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molcel.2008.12.013","article-title":"Protein arginine methylation in mammals: who, what, and why","volume":"33","author":"Bedford","year":"2009","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ymeth.2019.08.003_b0025","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.abb.2015.11.030","article-title":"Biochemistry and regulation of the protein arginine methyltransferases (PRMTs)","volume":"590","author":"Morales","year":"2016","journal-title":"Arch. Biochem. Biophys."},{"issue":"13","key":"10.1016\/j.ymeth.2019.08.003_b0030","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/j.febslet.2010.11.010","article-title":"Histone arginine methylation","volume":"585","author":"Di Lorenzo","year":"2011","journal-title":"FEBS Lett."},{"issue":"1","key":"10.1016\/j.ymeth.2019.08.003_b0035","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nrc3409","article-title":"Protein arginine methyltransferases and cancer","volume":"13","author":"Yang","year":"2013","journal-title":"Nat. Rev. Cancer"},{"issue":"12","key":"10.1016\/j.ymeth.2019.08.003_b0040","doi-asserted-by":"crossref","first-page":"24412","DOI":"10.3390\/ijms141224412","article-title":"Biological functional relevance of asymmetric dimethylarginine (ADMA) in cardiovascular disease","volume":"14","author":"Franceschelli","year":"2013","journal-title":"Int. J. Mol. Sci."},{"issue":"15","key":"10.1016\/j.ymeth.2019.08.003_b0045","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1111\/bph.14361","article-title":"Inhibition of protein arginine methyltransferase 3 activity selectively impairs liver X receptor-driven transcription of hepatic lipogenic genes in vivo","volume":"175","author":"Nahon","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ymeth.2019.08.003_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2466-9-5","article-title":"From arginine methylation to ADMA: a novel mechanism with therapeutic potential in chronic lung diseases","volume":"9","author":"Zakrzewicz","year":"2009","journal-title":"BMC Pulm. Med."},{"issue":"10","key":"10.1016\/j.ymeth.2019.08.003_b0055","doi-asserted-by":"crossref","first-page":"12383","DOI":"10.3390\/ijms131012383","article-title":"Protein arginine methyltransferases (PRMTs): promising targets for the treatment of pulmonary disorders","volume":"13","author":"Zakrzewicz","year":"2012","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.ymeth.2019.08.003_b0060","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.1128\/JVI.01888-06","article-title":"Arginine methylation of the human immunodeficiency virus type 1 tat protein by PRMT6 negatively affects tat interactions with both cyclin T1 and the tat transactivation region","volume":"81","author":"Xie","year":"2007","journal-title":"J. Virol."},{"issue":"16","key":"10.1016\/j.ymeth.2019.08.003_b0065","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1182\/blood-2014-12-619783","article-title":"Selective inhibition of protein arginine methyltransferase 5 blocks initiation and maintenance of B-cell transformation","volume":"125","author":"Pileri","year":"2015","journal-title":"Blood"},{"issue":"21","key":"10.1016\/j.ymeth.2019.08.003_b0070","doi-asserted-by":"crossref","first-page":"9429","DOI":"10.1021\/acs.jmedchem.8b00598","article-title":"Protein arginine methyltransferase 5 (PRMT5) as an anticancer target and its inhibitor discovery","volume":"61","author":"Wang","year":"2018","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.ymeth.2019.08.003_b0075","doi-asserted-by":"crossref","DOI":"10.1039\/C4OB01734J","article-title":"Synthesis and evaluation of protein arginine N-methyltransferase inhibitors designed to simultaneously occupy both substrate binding sites","volume":"13","author":"Van Haren","year":"2015","journal-title":"Org. Biomol. Chem."},{"issue":"14","key":"10.1016\/j.ymeth.2019.08.003_b0080","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1073\/pnas.1618401114","article-title":"Transition state mimics are valuable mechanistic probes for structural studies with the arginine methyltransferase CARM1","volume":"114","author":"van Haren","year":"2017","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"26","key":"10.1016\/j.ymeth.2019.08.003_b0085","doi-asserted-by":"crossref","first-page":"19866","DOI":"10.1074\/jbc.M000023200","article-title":"Protein-arginine methyltransferase i, the predominant protein-arginine methyltransferase in cells, interacts with and is regulated by interleukin enhancer-binding factor 3","volume":"275","author":"Tang","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"24","key":"10.1016\/j.ymeth.2019.08.003_b0090","doi-asserted-by":"crossref","first-page":"4597","DOI":"10.4161\/cc.22871","article-title":"Alternatively spliced protein arginine methyltransferase 1 isoform PRMT1v2 promotes the survival and invasiveness of breast cancer cells","volume":"11","author":"Baldwin","year":"2012","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ymeth.2019.08.003_b0095","doi-asserted-by":"crossref","first-page":"41","DOI":"10.18632\/oncotarget.11376","article-title":"Protein arginine methylation\/demethylation and cancer","volume":"7","author":"Poulard","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.ymeth.2019.08.003_b0100","doi-asserted-by":"crossref","first-page":"298","DOI":"10.4049\/jimmunol.1402465","article-title":"PRMT1 upregulated by epithelial proinflammatory cytokines participates in COX2 expression in fibroblasts and chronic antigen-induced pulmonary inflammation","volume":"195","author":"Liu","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.ymeth.2019.08.003_b0105","doi-asserted-by":"crossref","first-page":"(1)","DOI":"10.1038\/s41467-018-07606-y","article-title":"Cardiac specific PRMT1 ablation causes heart failure through CaMKII dysregulation","volume":"9","author":"Pyun","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymeth.2019.08.003_b0110","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.isci.2018.09.023","article-title":"PRMT1 deficiency in mouse juvenile heart induces dilated cardiomyopathy and reveals cryptic alternative splicing products","volume":"8","author":"Murata","year":"2018","journal-title":"iScience"},{"issue":"23","key":"10.1016\/j.ymeth.2019.08.003_b0115","doi-asserted-by":"crossref","first-page":"20323","DOI":"10.1074\/jbc.M110.207258","article-title":"Histone H4 acetylation differentially modulates arginine methylation by an in cis mechanism","volume":"286","author":"Feng","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.ymeth.2019.08.003_b0120","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1074\/jbc.M108786200","article-title":"The novel human protein arginine N-methyltransferase PRMT6 is a nuclear enzyme displaying unique substrate specificity","volume":"277","author":"Frankel","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ymeth.2019.08.003_b0125","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1530\/ERC-13-0375","article-title":"Deregulated expression of selected histone methylases and demethylases in prostate carcinoma","volume":"21","author":"Henrique","year":"2013","journal-title":"Endocr. Relat. Cancer"},{"issue":"6","key":"10.1016\/j.ymeth.2019.08.003_b0130","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.ejca.2012.11.026","article-title":"Deregulation of protein methylation in melanoma","volume":"49","author":"Limm","year":"2013","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.ymeth.2019.08.003_b0135","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1128\/JVI.79.1.124-131.2005","article-title":"Methylation of tat by PRMT6 regulates human immunodeficiency virus type 1 gene expression","volume":"79","author":"Boulanger","year":"2005","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.ymeth.2019.08.003_b0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-4690-10-73","article-title":"Automethylation of protein arginine methyltransferase 6 (PRMT6) regulates its stability and its anti-HIV-1 activity","volume":"10","author":"Singhroy","year":"2013","journal-title":"Retrovirology"},{"issue":"19","key":"10.1016\/j.ymeth.2019.08.003_b0145","doi-asserted-by":"crossref","first-page":"7849","DOI":"10.1021\/jo801517f","article-title":"Preparation of NG-substituted l-arginine analogues suitable for solid phase peptide synthesis","volume":"73","author":"Martin","year":"2008","journal-title":"J. Org. Chem."},{"issue":"46","key":"10.1016\/j.ymeth.2019.08.003_b0150","doi-asserted-by":"crossref","first-page":"13370","DOI":"10.1021\/bi701558t","article-title":"Protein arginine methyltransferase 1: positively charged residues in substrate peptides distal to the site of methylation are important for substrate binding and catalysis","volume":"46","author":"Osborne","year":"2007","journal-title":"Biochemistry"},{"issue":"14","key":"10.1016\/j.ymeth.2019.08.003_b0155","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1073\/pnas.1618401114","article-title":"Transition state mimics are valuable mechanistic probes for structural studies with the arginine methyltransferase CARM1","volume":"114","author":"van Haren","year":"2017","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"2","key":"10.1016\/j.ymeth.2019.08.003_b0160","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0003-2697(70)90146-6","article-title":"Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides","volume":"34","author":"Kaiser","year":"1970","journal-title":"Anal. Biochem."},{"issue":"1","key":"10.1016\/j.ymeth.2019.08.003_b0165","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0003-2697(81)90704-1","article-title":"Quantitative monitoring of solid-phase peptide synthesis by the ninhydrin reaction","volume":"117","author":"Sarin","year":"1981","journal-title":"Anal. Biochem."},{"issue":"3","key":"10.1016\/j.ymeth.2019.08.003_b0170","first-page":"763","article-title":"Structural insights into ternary complex formation of human CARM1 with various substrates","volume":"11","author":"Moradei","year":"2015","journal-title":"ACS Chem. Biol."},{"issue":"14 Suppl.","key":"10.1016\/j.ymeth.2019.08.003_b0175","article-title":"Abstract LB-017: disordered methionine metabolism in MTAP\/CDKN2A-deleted cancers leads to marked dependence on PRMT5","volume":"76","author":"Mavrakis","year":"2016","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.ymeth.2019.08.003_b0180","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0969-2126(03)00071-6","article-title":"Structure of the predominant protein arginine methyltransferase PRMT1 and analysis of its binding to substrate peptides","volume":"11","author":"Zhang","year":"2003","journal-title":"Structure"},{"issue":"5","key":"10.1016\/j.ymeth.2019.08.003_b0185","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.str.2014.03.003","article-title":"Structural determinants for the strict monomethylation activity by Trypanosoma brucei protein arginine methyltransferase 7","volume":"22","author":"Liu","year":"2014","journal-title":"Structure"}],"container-title":["Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1046202319301239?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1046202319301239?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T01:36:29Z","timestamp":1760924189000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1046202319301239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":37,"alternative-id":["S1046202319301239"],"URL":"https:\/\/doi.org\/10.1016\/j.ymeth.2019.08.003","relation":{},"ISSN":["1046-2023"],"issn-type":[{"value":"1046-2023","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peptidic transition state analogues as PRMT inhibitors","name":"articletitle","label":"Article Title"},{"value":"Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymeth.2019.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}